PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Batten Disease Family Association, Hamilton House, Mabledon Place, London, WC1H9BB, UK. amandamortensen@bdfa-uk.org.uk.\', \'Rare Disease Research Partners, MPS House, Amersham, HP7 9LP, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13023-021-02147-y
?:hasPublicationType
?:journal
  • Orphanet journal of rare diseases
is ?:pmid of
?:pmid
?:pmid
  • 35045884
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.413
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatment.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35045884>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35045884>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all